Regulatory T cells in the tissues
Thursday 29th June at 1.30pm, room P. Druet Dr. Adrian Liston – Babraham Institute Contact: benoit.salomon@inserm.frPreparing human mucosal immune barriers for the next pandemic
Wednesday 28th June at 1.30pm, room P. Druet Dr. James di Santo – Institut Pasteur Contact: roland.liblau@inserm.fr
A caffeinated journey in Alzheimer’s Disease
Friday 16th June at 11am, room J. Ruffié Dr. David Blum – Lille Neuroscience et Cognition Contact: elsa.suberbielle@inserm.frIdentification of regulatory cell-cell interactions in CNS inflammation
Thuesday 23 rd May at 1.30pm, room P. Druet Dr. Francisco J. Quintana – Harvard University Contact roland.liblau@inserm.fr
The Role of EOMES+Tr1-like cells in multiple sclerosis
Thursday 15 Th June at 1.30pm, room P. Druet Dr. Jens GEGINAT – INGM, Milan Contact anne.astier@inserm.frDouble edged influence of TLR7 and TLR9 on the triggering and severity of lupus
Thursday 8Th June at 1.30pm, room P. Druet Dr. Claire Leibler – Immunoconcept, Bordeaux Contact jean-charles.guery@inserm.fr
Lost in space: how ageing alters Tfh cell localisation and the consequences for the germinal centre response
Thursday 20Th April at 1.30pm, room P Druet Dr. Michelle Linterman – Babraham Institute, Cambridge Contact benoit.salomon@inserm.fr
Harnessing myeloid cell diversity to fight obesity
Thursday 13rd April at 1.30pm, room P Druet Dr. Svetoslav Chakarov – Shangai Institute of Immunology Contact nicolas.fazilleau@inserm.fr
Novel diagnostic and therapeutic approaches for IgE-mediated allergies
Thursday 6Th April at 1.30pm, room P Druet Dr. Alexander Eggel – Universitat Bern Contact laurent.reber@inserm.frThesis defenses: Le rôle du facteur de transcription Eomes dans la modulation de la réponse antitumorale des LT au cours de la thérapie ciblant 4-1BB
Monday 6Th March, 2023 Arantxa AGESTA Le rôle du facteur de transcription Eomes dans la modulation de la réponse antitumorale des LT au cours de la thérapie ciblant 4-1BB